Korro Bio Inc. (NASDAQ: KRRO)
$48.61
-3.7400 ( -7.14% ) 34.5K
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Market Data
Open
$48.61
Previous close
$52.35
Volume
34.5K
Market cap
$448.35M
Day range
$47.33 - $52.24
52 week range
$14.00 - $97.91
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 13, 2023 |
4 | Insider transactions | 1 | Jul 13, 2023 |
4 | Insider transactions | 1 | Jul 13, 2023 |
4/a | Other | 1 | Jul 12, 2023 |
4/a | Other | 1 | Jul 12, 2023 |
4/a | Other | 1 | Jul 12, 2023 |
4/a | Other | 1 | Jul 12, 2023 |
4/a | Other | 1 | Jul 12, 2023 |
4/a | Other | 1 | Jul 12, 2023 |
4 | Insider transactions | 1 | Jul 11, 2023 |